ERBB2 and sarcoma: More recently, 10 HER2+ sarcoma patients received up to three infusions of 1 × 108 CAR T-cells/m2, each administered after lymphodepletion followed by up to 5 subsequent infusions without lymphodepletion (NCT00902044) [25].